China Universal Asset Management »

Cartesian Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $47k 4.6k 10.22
2025-06-30 $54k 5.2k 10.39
2025-03-31 $67k 5.1k 13.18
2024-12-31 $97k 5.4k 17.91

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Siren
Vanguard Group
MPM Oncology Impact Management
Erste Asset Management GmbH
Geode Capital Management
683 Capital Management
State Street Corporation
Susquehanna International
Northern Trust
Citadel Advisors
GSA Capital Partners
Marshall Wace
Royal Bank of Canada

View all funds holding Cartesian Therapeutics